In Vivo Gastric Expression of FTO and MC4R in Sleeve Gastrectomy Patients: Diagnostic Utility Without Predictive Value for Weight Loss - Top-Institutions - MDSpire

In Vivo Gastric Expression of FTO and MC4R in Sleeve Gastrectomy Patients: Diagnostic Utility Without Predictive Value for Weight Loss

  • By

  • Mohamed Hany

  • Mona K. ElDeeb

  • Ehab Elmongui

  • Anwar Ashraf Abouelnasr

  • Noha A. El-Banna

  • Sahar M. omer

  • Sara A. Shaker

  • Rasha A. ElTahan

  • December 9, 2025

  • 0 min

Share

Top Institutions in Surgery

Brief introduction explaining scope and methodology.

  • #1

    Harvard Medical School
    Harvard Medical School

    Boston, MA

    Key Differentiators

    • Obesity Genetics
    • Metabolic Surgery
    • Translational Medicine

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Metabolic Surgery
    • Genetic Epidemiology
    • Endocrinology

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Genetics
    • Obesity Research
    • Bariatric Surgery

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Metabolic and Bariatric Surgery
    • Molecular Genetics
    • Endocrinology

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Bariatric Surgery
    • Obesity Genetics
    • Metabolic Disease

Original Source(s)

In Vivo Gastric Expression of FTO and MC4R in Sleeve Gastrectomy Patients: Diagnostic Utility Without Predictive Value for Weight Loss

  • by Mohamed Hany, Mona K. ElDeeb, Ehab Elmongui, Anwar Ashraf Abouelnasr, Noha A. El-Banna, Sahar M. omer, Sara A. Shaker, Rasha A. ElTahan

  • December 9, 2025

Related Content

Medical Oddities: Ancient Practice Calms Modern BP

Ancient workouts, anxious ears, tea gains, limb regrowth, and furry tongues collide.

Venous Thromboembolism and Bleeding Risk in a Population with Obesity Hospitalized for Surgery and Receiving Enoxaparin for Thromboprophylaxis

A Smarter Screen for Sleep Apnea Stimulation

A four-factor staging system stratified response rates from 90.9% to 37.5% in a retrospective cohort study, although the model showed only moderate discrimination (C statistic, 0.68) and requires external validation